GENE ONLINE|News &
Opinion
Blog

Biosimilar
Trials & Approvals Biosimilar
Celltrion’s Avastin Biosimilar Gets FDA Greenlight
2022-09-29
Licensing China
Organon Licenses Biosimilars From Shanghai’s Henlius For $103 Million
2022-06-14
Trials & Approvals Biosimilar
Alymsys Becomes the Third Biosimilar for Bevacizumab Approved by FDA
2022-04-20
M&A Biosimilar
BBL to Take Over Biosimilars Business from Viatris 
2022-03-02
Technology HUMIRA
The Next SuperStar Drug? AbbVie Places its Hope on Skyrizi and Rinvoq
2022-02-16
Asia-Pacific Biosimilar
Samsung Biologics Snaps Up Biogen’s Stake in Samsung Bioepis for $2.3 Billion, Assuming Full Control of Biosimilar Venture
2022-01-28
Trials & Approvals
FDA Approves Samsung Bioepis and Biogen’s Lucentis Biosimilar
2021-09-22
Asia-Pacific
South Korea’s Boryung Launches Avastin Biosimilar Developed by Samsung Bioepis
2021-09-02
Biosimilar
Addressing The Global Need for Biosimilars: Current Trends, Expectations and Real World Experiences
2021-08-26
Trials & Approvals Asthma
Novartis, Genentech Bag Key FDA Okay for Blockbuster Drug
2021-04-14
Anti-TNF
Korea Made Humira Biosimilar Begins Sales in Australia, Marks its Presence in Third Overseas Market
2021-03-31
Two South Korean Companies Look to Capture the Biosimilars Market Worth Billions
2020-12-01
Trials & Approvals Rituximab
Innovent Biologics Bags Chinese Approval for Fourth Monoclonal Antibody
2020-10-12
M&A Japan
Sandoz Acquires Aspen’s Japanese Operation, Strengthens Hold in Japanese Market
2020-02-02
Asia-Pacific Lazada Group
Weekly in Asia ｜Nov
2019-11-12
1 2
LATEST
Axsome’s AXS-05 Achieves Endpoints In Alzheimer’s Agitation Trial
2022-11-29
Spectrum to Cut 75% of Staff and NSCLC Program Following CLR
2022-11-28
Full-Life Technologies to Acquire Focus-X Therapeutics, Bolstering Peptide-Focused Radiopharmaceutical Pipeline
2022-11-28
Medeologix Acquires Three Silicon Valley Medical Device CDMO Companies and Establishes One-Stop Shop Mass Production Facilities in Taiwan
2022-11-28
GenFleet Therapeutics to Present Data from Phase I Trial of GFH009 Monotherapy at the 2022 Annual Meeting of American Society of Hematology (ASH)
2022-11-28
Everest’s Renal Drug Gets Placed On Fast Track For Approval In Taiwan And Korea
2022-11-28
Canada Authorizes Roche’s Polivy as First-Line Lymphoma Treatment
2022-11-27
READ MORE
EVENT
2022-12-01
BIOCHINA 2022
Online
2022-12-10
64TH ASH ANNUAL MEETING & EXPOSITION
New Orleans, USA
2022-12-14
BIOHK2022
Hong Kong, China
2023-01-07
7th Asia Microbiome Conference
Taipei, Taiwan
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2022 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top

Enjoy Your First 14 Days for $1.49

SUBSCRIBE NOW

Create an account with us now to say goodbye to all the pop-ups!